New authorisations for Instillagel

In the last few months, Farco-Pharma GmbH has been able to meet additional conditions for market access following a process that was very drawn-out at times. The Regulatory Affairs and Clinical Trials Department has obtained new authorisations for Instillagel in Israel and South Africa.

However, the product is approved under the name "Endostil" in South Africa; Instillagel was not accepted by the regulatory authority.